• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model.在小鼠肺癌模型的淋巴细胞减少条件下,抗肿瘤免疫反应对白介素7信号的需求。
Cancer Immunol Immunother. 2016 Mar;65(3):341-54. doi: 10.1007/s00262-016-1808-7. Epub 2016 Feb 15.
2
IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.IL7-Fc 增强了嵌合抗原受体 T 细胞疗法在荷瘤小鼠模型中的疗效。
Cells. 2021 Aug 7;10(8):2018. doi: 10.3390/cells10082018.
3
Elevated IL-7 availability does not account for T cell proliferation in moderate lymphopenia.IL-7可用性升高并不能解释中度淋巴细胞减少时的T细胞增殖。
J Immunol. 2011 Feb 15;186(4):1981-8. doi: 10.4049/jimmunol.1002224. Epub 2011 Jan 14.
4
IL-18 synergizes with IL-7 to drive slow proliferation of naive CD8 T cells by costimulating self-peptide-mediated TCR signals.白细胞介素-18与白细胞介素-7协同作用,通过共刺激自身肽介导的T细胞受体信号,促使初始CD8 T细胞缓慢增殖。
J Immunol. 2014 Oct 15;193(8):3992-4001. doi: 10.4049/jimmunol.1400396. Epub 2014 Sep 8.
5
Cutting Edge: Innate Lymphoid Cells Suppress Homeostatic T Cell Expansion in Neonatal Mice.前沿:天然淋巴细胞抑制新生小鼠体内稳态T细胞的扩增
J Immunol. 2016 May 1;196(9):3532-6. doi: 10.4049/jimmunol.1501643. Epub 2016 Mar 16.
6
Induction of antitumor immune response by homeostatic proliferation and CD28 signaling.通过稳态增殖和CD28信号传导诱导抗肿瘤免疫反应。
J Immunol. 2008 Apr 1;180(7):4596-605. doi: 10.4049/jimmunol.180.7.4596.
7
Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation.经淋巴细胞减少诱导增殖后,自身特异性 CD8+ T 细胞保持半幼稚状态。
J Immunol. 2010 May 15;184(10):5604-11. doi: 10.4049/jimmunol.1000109. Epub 2010 Apr 14.
8
IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells.白细胞介素-15是持续淋巴细胞减少驱动的CD8 T细胞增殖和积累所必需的。
J Immunol. 2007 Jul 1;179(1):120-5. doi: 10.4049/jimmunol.179.1.120.
9
Irradiation and IL-15 promote loss of CD8 T-cell tolerance in response to lymphopenia.辐照和 IL-15 促进了对淋巴细胞减少的 CD8 T 细胞耐受的丧失。
Blood. 2010 Mar 18;115(11):2196-202. doi: 10.1182/blood-2009-06-227298. Epub 2010 Jan 14.
10
[Recipient lymphopenia state enhances the expansion and anti-leukemia effect of leukemia specific cytotoxic T lymphocytes].[受体淋巴细胞减少状态增强白血病特异性细胞毒性T淋巴细胞的扩增及抗白血病效应]
Zhonghua Xue Ye Xue Za Zhi. 2005 Aug;26(8):465-8.

引用本文的文献

1
Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer.联合全反式维甲酸靶向髓系来源抑制细胞治疗与冷冻-热疗增强乳腺癌的抗肿瘤免疫。
Front Immunol. 2022 Nov 1;13:1016776. doi: 10.3389/fimmu.2022.1016776. eCollection 2022.
2
Development of antigen-prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse.利用人白细胞抗原转基因小鼠开发个体化新抗原疫苗的抗原预测算法。
Cancer Sci. 2022 Apr;113(4):1113-1124. doi: 10.1111/cas.15291. Epub 2022 Mar 2.
3
Tumor-infiltrating CD62L+PD-1-CD8 T cells retain proliferative potential via Bcl6 expression and replenish effector T cells within the tumor.肿瘤浸润性 CD62L+PD-1-CD8 T 细胞通过 Bcl6 表达保留增殖潜能,并在肿瘤内补充效应 T 细胞。
PLoS One. 2020 Aug 26;15(8):e0237646. doi: 10.1371/journal.pone.0237646. eCollection 2020.
4
Genetic polymorphisms in and are correlated with lung cancer risk in the Chinese Han population.和中的基因多态性与中国汉族人群的肺癌风险相关。
Cancer Manag Res. 2019 Jun 11;11:5393-5401. doi: 10.2147/CMAR.S202839. eCollection 2019.
5
The perioperative dynamics of IL-7 following robot-assisted and open colorectal surgery.机器人辅助和开放性结直肠手术后白细胞介素 7 的围手术期动力学。
Sci Rep. 2018 Jun 14;8(1):9126. doi: 10.1038/s41598-018-27245-z.
6
Chemotherapy and immunotherapy: A close interplay to fight cancer?化疗与免疫疗法:对抗癌症的紧密相互作用?
Oncoimmunology. 2016 Jun 21;5(7):e1190061. doi: 10.1080/2162402X.2016.1190061. eCollection 2016 Jul.
7
Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.基于蛋白质组学的肺癌细胞因子研究方法
Dis Markers. 2016;2016:2138627. doi: 10.1155/2016/2138627. Epub 2016 Jun 30.

本文引用的文献

1
Genetic basis for clinical response to CTLA-4 blockade in melanoma.黑色素瘤中CTLA-4阻断临床反应的遗传基础。
N Engl J Med. 2014 Dec 4;371(23):2189-2199. doi: 10.1056/NEJMoa1406498. Epub 2014 Nov 19.
2
Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody.在联合疫苗和抗 PD-1 抗体治疗后,消退肿瘤中记忆前体 CD8 T 细胞的积累。
Cancer Res. 2014 Jun 1;74(11):2974-85. doi: 10.1158/0008-5472.CAN-13-2564. Epub 2014 Apr 11.
3
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.拉罗替尼(anti-PD-1)治疗黑色素瘤的安全性和肿瘤应答。
N Engl J Med. 2013 Jul 11;369(2):134-44. doi: 10.1056/NEJMoa1305133. Epub 2013 Jun 2.
4
IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens.IL-7 和 IL-15 介导的 TCR 致敏使 T 细胞能够对自身抗原产生反应。
J Immunol. 2013 Feb 15;190(4):1416-23. doi: 10.4049/jimmunol.1201620. Epub 2013 Jan 16.
5
Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung.TLR3 激动剂全身给药可诱导肺部 IL-7 的表达和依赖 IL-7 的 CXCR3 配体产生。
J Leukoc Biol. 2013 Mar;93(3):413-25. doi: 10.1189/jlb.0712360. Epub 2012 Dec 27.
6
Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.抗白细胞介素-7 受体-α通过调节效应 T 细胞功能逆转非肥胖型糖尿病小鼠的 1 型糖尿病。
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12674-9. doi: 10.1073/pnas.1203795109. Epub 2012 Jun 25.
7
IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.IL-7 受体阻断通过促进抑制效应/记忆 T 细胞来逆转自身免疫性糖尿病。
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12668-73. doi: 10.1073/pnas.1203692109. Epub 2012 Jun 25.
8
Cellular constituents of immune escape within the tumor microenvironment.肿瘤微环境中的免疫逃逸细胞成分。
Cancer Res. 2012 Jul 1;72(13):3125-30. doi: 10.1158/0008-5472.CAN-11-4094. Epub 2012 Jun 21.
9
IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.IL-7 通过多种机制克服慢性病毒感染并限制器官病理。
Cell. 2011 Feb 18;144(4):601-13. doi: 10.1016/j.cell.2011.01.011. Epub 2011 Feb 3.
10
Tumor immune therapy: lessons from infection and implications for cancer - can IL-7 help overcome immune inhibitory networks?肿瘤免疫治疗:感染的启示及其对癌症的影响——IL-7 能否帮助克服免疫抑制网络?
Eur J Immunol. 2010 Jul;40(7):1852-61. doi: 10.1002/eji.201040603.

在小鼠肺癌模型的淋巴细胞减少条件下,抗肿瘤免疫反应对白介素7信号的需求。

Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model.

作者信息

Suzuki Toshihiro, Kishimoto Hidehiro, Abe Ryo

机构信息

Division of Immunobiology, Research Institute for Biomedical Sciences, Tokyo University of Science, 2669 Yamazaki, Noda, Chiba, 278-0022, Japan.

Parasitology and Immunopathoetiology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.

出版信息

Cancer Immunol Immunother. 2016 Mar;65(3):341-54. doi: 10.1007/s00262-016-1808-7. Epub 2016 Feb 15.

DOI:10.1007/s00262-016-1808-7
PMID:26880265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11028809/
Abstract

Induction of lymphopenia before adoptive transfer of T cells was followed by lymphopenia-induced proliferation (LIP) and generated a potent anti-tumor immune response in rodents and in a clinical setting. Previously, we reported that CD28 signaling is essential for the differentiation of functional effector cytotoxic T lymphocytes (CTLs) under lymphopenic conditions and sequential LIP of T cells. In this study, to clarify the correlation between LIP and the anti-tumor effect, LIP was inhibited with interleukin 7 (IL7) receptor blockade at various stages, and the anti-tumor effect then assessed. We confirmed that IL7 signaling at the start of LIP is crucial for the anti-tumor immune response. In contrast, continuous IL7 signaling was not required for tumor regression, although LIP of naïve CD8+ T cells is usually regulated by IL7. The expansion and migration of CTLs in lymphopenic hosts depend on IL7 signaling during the induction phase. Here, we propose that IL7 signaling and subsequent LIP of T cells have distinct roles in the induction of T cell immunity during lymphopenia.

摘要

在T细胞过继转移前诱导淋巴细胞减少,随后出现淋巴细胞减少诱导的增殖(LIP),并在啮齿动物和临床环境中产生有效的抗肿瘤免疫反应。此前,我们报道CD28信号对于淋巴细胞减少条件下功能性效应细胞毒性T淋巴细胞(CTL)的分化以及T细胞的序贯LIP至关重要。在本研究中,为了阐明LIP与抗肿瘤效应之间的相关性,在不同阶段用白细胞介素7(IL7)受体阻断抑制LIP,然后评估抗肿瘤效应。我们证实LIP开始时的IL7信号对于抗肿瘤免疫反应至关重要。相比之下,尽管初始CD8+T细胞的LIP通常受IL7调节,但肿瘤消退并不需要持续的IL7信号。在淋巴细胞减少的宿主中,CTL的扩增和迁移在诱导阶段依赖于IL7信号。在此,我们提出IL7信号及随后的T细胞LIP在淋巴细胞减少期间T细胞免疫的诱导中具有不同作用。